Results 171 to 180 of about 21,198 (196)

Evaluating the effectiveness of various treatment modalities in vulvar high-grade squamous intraepithelial lesions (vHSIL): a systematic review. [PDF]

Gynecol Oncol Rep
Vaessen VJGM, Sidera K, van de Laar RLO, van Beekhuizen HJ.   +3 more
europepmc   +1 more source

Progressive Giant Orf Disease With Recurring. [PDF]

J Hand Surg Glob Online
Tabrizi A, Afshar A, Abbasi A.
europepmc   +1 more source

Case Report: Epidermodysplasia verruciformis misdiagnosed as pityriasis alba in a child: a diagnostic pitfall in facial hypopigmented lesions. [PDF]

Front Immunol
Pan S, Tan Z, Zhang Y.
europepmc   +1 more source

Intestinal and Blood-Brain Barrier Dysfunction in Lupus: Emerging Mechanisms and Modulation by Cinnamon. [PDF]

Molecules
Maalouly G, Al Tekle GA, Al Achkar G, Fares N.   +3 more
europepmc   +1 more source

Pink lotus flower (<i>Nelumbo nucifera</i>) oil extract alleviates imiquimod-induced psoriasis-like dermatitis. [PDF]

Biomed Rep
Jongsomchai K, Sridurongrit S, Sukphopetch P, Rudtanatip T, Promsrisuk T, Phuapittayalert L, Jamsuwan S, Chanmanee T, Thummayot S, Thongrong S, Onsa-Ard A, Pudgerd A.   +11 more
europepmc   +1 more source

Efficacy of combined topical imiquimod, 5-fluorouracil, and tretinoin in the treatment of a basaloid atypical proliferation on the plantar surface in a patient who is nonsyndromic for basal cell nevus syndrome. [PDF]

JAAD Case Rep
Nahm WJ, Badiavas EV, Kirsner RS, Shen CL, Elgart GW.   +4 more
europepmc   +1 more source

Regulation of Imiquimod-Induced Mouse Psoriasis Development via Apoptosis Signal-Regulating Kinase 1 Potentially by Antagonizing Aryl Hydrocarbon Receptor Expression. [PDF]

Curr Issues Mol Biol
Hasegawa H, Watanabe A, Katahira Y, Mizoguchi I, Maeda T, Mizugami J, Naguro I, Ichijo H, Harada K, Okubo Y, Yoshimoto T.   +10 more
europepmc   +1 more source

Imiquimod in basal cell carcinoma: how does it work?

British Journal of Dermatology, 2003
Imiquimod is a topical immune response modifier that binds to Toll-like receptor-7 and -8, inducing interferon-alpha. We treated superficial basal cell carcinomas (BCC) with imiquimod 5% cream daily for 5-8 days.
Reinhard Dummer, Werner Kempf
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Imiquimod for vaginal intraepithelial neoplasia 2–3: A systematic review and meta-analysis

Gynecologic Oncology, 2021
Eiji Nakatani, Kenzo Kosaka
exaly  

Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model

Pharmaceutics, 2020
Alix Danoy, Bernard Verrier, Myriam Lamrayah   +2 more
exaly